Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Jelinek T, Zihala D, Zabaleta A, Kostopoulos IV, Soucek O, Venglar O, Moreno C, Fotiou D, Radova E, Tamariz-Amador LE, Theodorakakou F, Muronova L, Manubens A, Tsitsilonis O, Popkova T, Gonzalez C, Anilkumar Sithara A, Corrado F, Bidikian N, Guerrero C, Kapustova V, Bilek D, Hagner PR, Larrayoz M, Martinez Climent JA, Broskevicova L, Mihalyova J, Merz M, Sevcikova T, Ghobrial IM, San Miguel J, Dimopoulos MA, Rodriguez-Otero P, Radocha J, Kastritis E, Paiva B, Hajek R

Open source

DOI
10.1182/blood.2025029572
Published
2026 Mar 5
Container
Blood
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025029572,
  title = {Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.},
  author = {Jelinek T and Zihala D and Zabaleta A and Kostopoulos IV and Soucek O and Venglar O and Moreno C and Fotiou D and Radova E and Tamariz-Amador LE and Theodorakakou F and Muronova L and Manubens A and Tsitsilonis O and Popkova T and Gonzalez C and Anilkumar Sithara A and Corrado F and Bidikian N and Guerrero C and Kapustova V and Bilek D and Hagner PR and Larrayoz M and Martinez Climent JA and Broskevicova L and Mihalyova J and Merz M and Sevcikova T and Ghobrial IM and San Miguel J and Dimopoulos MA and Rodriguez-Otero P and Radocha J and Kastritis E and Paiva B and Hajek R},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025029572},
  url = {https://doi.org/10.1182/blood.2025029572}
}

RIS

TY  - JOUR
TI  - Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.
AU  - Jelinek T
AU  - Zihala D
AU  - Zabaleta A
AU  - Kostopoulos IV
AU  - Soucek O
AU  - Venglar O
AU  - Moreno C
AU  - Fotiou D
AU  - Radova E
AU  - Tamariz-Amador LE
AU  - Theodorakakou F
AU  - Muronova L
AU  - Manubens A
AU  - Tsitsilonis O
AU  - Popkova T
AU  - Gonzalez C
AU  - Anilkumar Sithara A
AU  - Corrado F
AU  - Bidikian N
AU  - Guerrero C
AU  - Kapustova V
AU  - Bilek D
AU  - Hagner PR
AU  - Larrayoz M
AU  - Martinez Climent JA
AU  - Broskevicova L
AU  - Mihalyova J
AU  - Merz M
AU  - Sevcikova T
AU  - Ghobrial IM
AU  - San Miguel J
AU  - Dimopoulos MA
AU  - Rodriguez-Otero P
AU  - Radocha J
AU  - Kastritis E
AU  - Paiva B
AU  - Hajek R
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025029572
UR  - https://doi.org/10.1182/blood.2025029572
ER  - 

APA

T, J., D, Z., A, Z., IV, K., O, S., O, V., C, M., D, F., E, R., LE, T., F, T., L, M., A, M., O, T., T, P., C, G., A, A. S., F, C., N, B., C, G., V, K., D, B., PR, H., M, L., JA, M. C., L, B., J, M., M, M., T, S., IM, G., J, S. M., MA, D., P, R., J, R., E, K., B, P., & R, H. (2026). Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.. Blood. https://doi.org/10.1182/blood.2025029572

Source records